Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Rice

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Pathogens and Disease|May 2, 2017
Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeuticsSanjay Ram, Jutamas Shaughnessy, Rosane B de Oliveira, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|November 19, 2016
A report of the automated radiosynthesis of the tau positron emission tomography radiopharmaceutical, [<sup>18</sup> F]-THK-5351Ramesh Neelamegam, Daniel L Yokell, Peter A Rice, et al.
Vaccine|April 24, 2009
Species-specificity of Neisseria gonorrhoeae infection: do human complement regulators contribute?Jutamas Ngampasutadol, Connie Tran, Sunita Gulati, et al.
BMC Infectious Diseases|November 28, 2014
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxoneSai Li, Xiao-Hong Su, Wen-Jing Le, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2016
Phase-Variable Heptose I Glycan Extensions Modulate Efficacy of 2C7 Vaccine Antibody Directed against Neisseria gonorrhoeae LipooligosaccharideSrinjoy Chakraborti, Lisa A Lewis, Andrew D Cox, et al.
Mbio|September 1, 2011
Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycansSarika Agarwal, Charles A Specht, Huang Haibin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 18, 2011
A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccinationPeter T Beernink, Jutamas Shaughnessy, Emily M Braga, et al.
Infection and Immunity|October 22, 2005
Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in GonococciSunita Gulati, Andrew Cox, Lisa A Lewis, et al.
Infection and Immunity|November 7, 2007
Defining targets for complement components C4b and C3b on the pathogenic neisseriaeLisa A Lewis, Sanjay Ram, Alpana Prasad, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasionJutamas Ngampasutadol, Sanjay Ram, Sunita Gulati, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Pathogens and Disease|May 2, 2017
Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeuticsSanjay Ram, Jutamas Shaughnessy, Rosane B de Oliveira, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|November 19, 2016
A report of the automated radiosynthesis of the tau positron emission tomography radiopharmaceutical, [<sup>18</sup> F]-THK-5351Ramesh Neelamegam, Daniel L Yokell, Peter A Rice, et al.
Vaccine|April 24, 2009
Species-specificity of Neisseria gonorrhoeae infection: do human complement regulators contribute?Jutamas Ngampasutadol, Connie Tran, Sunita Gulati, et al.
BMC Infectious Diseases|November 28, 2014
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxoneSai Li, Xiao-Hong Su, Wen-Jing Le, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2016
Phase-Variable Heptose I Glycan Extensions Modulate Efficacy of 2C7 Vaccine Antibody Directed against Neisseria gonorrhoeae LipooligosaccharideSrinjoy Chakraborti, Lisa A Lewis, Andrew D Cox, et al.
Mbio|September 1, 2011
Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycansSarika Agarwal, Charles A Specht, Huang Haibin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 18, 2011
A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccinationPeter T Beernink, Jutamas Shaughnessy, Emily M Braga, et al.
Infection and Immunity|October 22, 2005
Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in GonococciSunita Gulati, Andrew Cox, Lisa A Lewis, et al.
Infection and Immunity|November 7, 2007
Defining targets for complement components C4b and C3b on the pathogenic neisseriaeLisa A Lewis, Sanjay Ram, Alpana Prasad, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasionJutamas Ngampasutadol, Sanjay Ram, Sunita Gulati, et al.
Pageof 10